Wellesley Investment Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$593K Sell
7,699
-615
-7% -$46.9K 0.2% 54
2020
Q2
$609K Sell
8,314
-982
-11% -$69.8K 0.22% 51
2020
Q1
$616K Buy
+9,296
New +$656K 0.24% 50
2019
Q4
Sell
-3,259
Closed -$240K 121
2019
Q3
$240K Buy
3,259
+52
+2% +$3.77K 0.08% 97
2019
Q2
$229K Sell
3,207
-149
-4% -$10.6K 0.08% 99
2019
Q1
$230K Sell
3,356
-715
-18% -$46.2K 0.08% 111
2018
Q4
$242K Sell
4,071
-431
-10% -$27K 0.09% 107
2018
Q3
$301K Buy
4,502
+1
+0% +$67 0.1% 103
2018
Q2
$291K Buy
4,501
+32
+0.7% +$2.09K 0.1% 104
2018
Q1
$320K Buy
4,469
+185
+4% +$13.3K 0.12% 91
2017
Q4
$323K Hold
4,284
0.12% 92
2017
Q3
$312K Buy
4,284
+293
+7% +$21.1K 0.13% 89
2017
Q2
$295K Buy
3,991
+11
+0.3% +$817 0.12% 88
2017
Q1
$291K Hold
3,980
0.13% 89
2016
Q4
$260K Buy
+3,980
New +$273K 0.13% 93

Other funds holding CL

Wellesley Investment Partners's CL Position: Q3 2020 in Review

Wellesley Investment Partners reduced its Colgate-Palmolive (CL) stake by 7.4% in Q3 2020, selling an estimated $46.9K and leaving 7,699 shares worth $593K. The position accounts for 0.2% of the portfolio, ranked #54.

Wellesley Investment Partners first reported a position in CL in Q4 2016 and has held it in 15 quarters since. The position peaked at $616K in Q1 2020. 1,530 funds tracked by Wall St. Rank hold CL as of Q3 2020.

  • Wellesley Investment Partners held 7,699 shares of Colgate-Palmolive worth $593K as of Q3 2020.
  • Wellesley Investment Partners sold 615 Colgate-Palmolive shares in Q3 2020, an estimated $46.9K.
  • Colgate-Palmolive made up 0.2% of Wellesley Investment Partners's portfolio in Q3 2020, its #54 holding.
  • Wellesley Investment Partners first reported a position in Colgate-Palmolive in Q4 2016 and has held it in 15 quarters since.
  • Wellesley Investment Partners's Colgate-Palmolive position peaked at $616K in Q1 2020.
  • 1,530 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2020.

Based on Wellesley Investment Partners's 13F filing for Q3 2020, filed 30 Oct 2020.